Back
Yext, Inc. Vs. Olema Pharmaceuticals, Inc. Industry Stock Comparison
Buy
52
YEXT
Yext, Inc.
Last Price:
$8.42
Seasonality Move:
0.84%
Buy
66
OLMA
Olema Pharmaceuticals, Inc.
Last Price:
$31.53
Seasonality Move:
-6.94%
Buy
52
Yext, Inc. (YEXT)
is a Buy
Is Yext, Inc. a Buy, Sell or Hold?
-
The current Yext, Inc. [YEXT] share price is $8.38. The Score for YEXT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
-
YEXT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
66
Olema Pharmaceuticals, Inc. (OLMA)
is a Buy
Is Olema Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Olema Pharmaceuticals, Inc. [OLMA] share price is $30.68. The Score for OLMA is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
OLMA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
YEXT Stock Price Chart
What is Yext, Inc.'s stock price today?
-
The Yext, Inc. share price today is $8.38The current trend is moderately bullish and YEXT is experiencing selling pressure, which indicates risk of future bearish movement.
OLMA Stock Price Chart
What is Olema Pharmaceuticals, Inc.'s stock price today?
-
The Olema Pharmaceuticals, Inc. share price today is $30.68Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and OLMA is experiencing slight selling pressure.
YEXT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.47 | Buy |
| Relative Strength Index (14 RSI): | 43.56 | Sell |
| Chaikin Money Flow: | 419847 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
OLMA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.69 | Buy |
| Relative Strength Index (14 RSI): | 80.55 | Buy |
| Chaikin Money Flow: | 6400058 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
YEXT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 8.65 | Sell |
| 20-day SMA: | 8.51 | Sell |
| 50-day SMA: | 8.46 | Sell |
| 200-day SMA: | 7.77 | Buy |
| 8-day EMA: | 8.54 | Sell |
| 20-day EMA: | 7.51 | Buy |
| 50-day EMA: | 4.85 | Buy |
| 200-day EMA: | 1.61 | Buy |
OLMA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 27.81 | Buy |
| 20-day SMA: | 22.38 | Buy |
| 50-day SMA: | 14.55 | Buy |
| 200-day SMA: | 7.46 | Buy |
| 8-day EMA: | 27.53 | Buy |
| 20-day EMA: | 23.23 | Buy |
| 50-day EMA: | 16.87 | Buy |
| 200-day EMA: | 9.95 | Buy |
Yext, Inc. Earnings Growth & YEXT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.01 per share, an increase this year of $0.04 per share, and an increase next year of $0.20 per share.
Olema Pharmaceuticals, Inc. Earnings Growth & OLMA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.59 per share, and a decrease next year of $0.42 per share.
Yext, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Olema Pharmaceuticals, Inc. Technical Analysis
| Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||